You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
| Title |
Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations
|
|---|---|
| Published in |
Trials, January 2021
|
| DOI | 10.1186/s13063-020-04997-6 |
| Pubmed ID |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 62% |
| Netherlands | 1 | 8% |
| United Kingdom | 1 | 8% |
| Unknown | 3 | 23% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 69% |
| Scientists | 4 | 31% |
Mendeley readers
The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 108 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 17 | 16% |
| Other | 10 | 9% |
| Researcher | 9 | 8% |
| Student > Ph. D. Student | 8 | 7% |
| Student > Doctoral Student | 7 | 6% |
| Other | 20 | 19% |
| Unknown | 37 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 24% |
| Nursing and Health Professions | 18 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Unspecified | 4 | 4% |
| Engineering | 3 | 3% |
| Other | 17 | 16% |
| Unknown | 36 | 33% |